skip to main content
Idioma:
previous page 1 Resultados 2 3 4 5 next page
Mostrar Somente
Refinado por: assunto: Aged remover
Result Number Material Type Add to My Shelf Action Record Details and Options
11
Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer
Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer

Gandhi, Leena ; Rodríguez-Abreu, Delvys ; Gadgeel, Shirish ; Esteban, Emilio ; Felip, Enriqueta ; De Angelis, Flávia ; Domine, Manuel ; Clingan, Philip ; Hochmair, Maximilian J ; Powell, Steven F ; Cheng, Susanna Y.-S ; Bischoff, Helge G ; Peled, Nir ; Grossi, Francesco ; Jennens, Ross R ; Reck, Martin ; Hui, Rina ; Garon, Edward B ; Boyer, Michael ; Rubio-Viqueira, Belén ; Novello, Silvia ; Kurata, Takayasu ; Gray, Jhanelle E ; Vida, John ; Wei, Ziwen ; Yang, Jing ; Raftopoulos, Harry ; Pietanza, M. Catherine ; Garassino, Marina C

The New England journal of medicine, 2018-05, Vol.378 (22), p.2078-2092 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
12
Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden
Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden
Material Type:
Artigo 		Adicionar ao Meu Espaço

Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden

Hellmann, Matthew D ; Ciuleanu, Tudor-Eliade ; Pluzanski, Adam ; Lee, Jong Seok ; Otterson, Gregory A ; Audigier-Valette, Clarisse ; Minenza, Elisa ; Linardou, Helena ; Burgers, Sjaak ; Salman, Pamela ; Borghaei, Hossein ; Ramalingam, Suresh S ; Brahmer, Julie ; Reck, Martin ; O’Byrne, Kenneth J ; Geese, William J ; Green, George ; Chang, Han ; Szustakowski, Joseph ; Bhagavatheeswaran, Prabhu ; Healey, Diane ; Fu, Yali ; Nathan, Faith ; Paz-Ares, Luis

The New England journal of medicine, 2018-05, Vol.378 (22), p.2093-2104 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
13
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
Material Type:
Artigo 		Adicionar ao Meu Espaço

Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC

Antonia, Scott J ; Villegas, Augusto ; Daniel, Davey ; Vicente, David ; Murakami, Shuji ; Hui, Rina ; Kurata, Takayasu ; Chiappori, Alberto ; Lee, Ki H ; de Wit, Maike ; Cho, Byoung C ; Bourhaba, Maryam ; Quantin, Xavier ; Tokito, Takaaki ; Mekhail, Tarek ; Planchard, David ; Kim, Young-Chul ; Karapetis, Christos S ; Hiret, Sandrine ; Ostoros, Gyula ; Kubota, Kaoru ; Gray, Jhanelle E ; Paz-Ares, Luis ; de Castro Carpeño, Javier ; Faivre-Finn, Corinne ; Reck, Martin ; Vansteenkiste, Johan ; Spigel, David R ; Wadsworth, Catherine ; Melillo, Giovanni ; Taboada, Maria ; Dennis, Phillip A ; Özgüroğlu, Mustafa

The New England journal of medicine, 2018-12, Vol.379 (24), p.2342-2350 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
14
Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non-Small-Cell Lung Cancer
Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non-Small-Cell Lung Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non-Small-Cell Lung Cancer

Gadgeel, Shirish ; Rodríguez-Abreu, Delvys ; Speranza, Giovanna ; Esteban, Emilio ; Felip, Enriqueta ; Dómine, Manuel ; Hui, Rina ; Hochmair, Maximilian J ; Clingan, Philip ; Powell, Steven F ; Cheng, Susanna Yee-Shan ; Bischoff, Helge G ; Peled, Nir ; Grossi, Francesco ; Jennens, Ross R ; Reck, Martin ; Garon, Edward B ; Novello, Silvia ; Rubio-Viqueira, Belén ; Boyer, Michael ; Kurata, Takayasu ; Gray, Jhanelle E ; Yang, Jing ; Bas, Tuba ; Pietanza, M Catherine ; Garassino, Marina C

Journal of clinical oncology, 2020-05, Vol.38 (14), p.1505-1517 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
15
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer

Reck, Martin ; Rodríguez-Abreu, Delvys ; Robinson, Andrew G ; Hui, Rina ; Csőszi, Tibor ; Fülöp, Andrea ; Gottfried, Maya ; Peled, Nir ; Tafreshi, Ali ; Cuffe, Sinead ; O’Brien, Mary ; Rao, Suman ; Hotta, Katsuyuki ; Leiby, Melanie A ; Lubiniecki, Gregory M ; Shentu, Yue ; Rangwala, Reshma ; Brahmer, Julie R

The New England journal of medicine, 2016-11, Vol.375 (19), p.1823-1833 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
16
Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer
Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer

Antonia, Scott J ; Villegas, Augusto ; Daniel, Davey ; Vicente, David ; Murakami, Shuji ; Hui, Rina ; Yokoi, Takashi ; Chiappori, Alberto ; Lee, Ki H ; de Wit, Maike ; Cho, Byoung C ; Bourhaba, Maryam ; Quantin, Xavier ; Tokito, Takaaki ; Mekhail, Tarek ; Planchard, David ; Kim, Young-Chul ; Karapetis, Christos S ; Hiret, Sandrine ; Ostoros, Gyula ; Kubota, Kaoru ; Gray, Jhanelle E ; Paz-Ares, Luis ; de Castro Carpeño, Javier ; Wadsworth, Catherine ; Melillo, Giovanni ; Jiang, Haiyi ; Huang, Yifan ; Dennis, Phillip A ; Özgüroğlu, Mustafa

The New England journal of medicine, 2017-11, Vol.377 (20), p.1919-1929 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
17
Maintenance bevacizumab–pemetrexed after first-line cisplatin–pemetrexed–bevacizumab for advanced nonsquamous nonsmall-cell lung cancer: updated survival analysis of the AVAPERL (MO22089) randomized phase III trial
Maintenance bevacizumab–pemetrexed after first-line cisplatin–pemetrexed–bevacizumab for advanced nonsquamous nonsmall-cell lung cancer: updated survival analysis of the AVAPERL (MO22089) randomized phase III trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Maintenance bevacizumab–pemetrexed after first-line cisplatin–pemetrexed–bevacizumab for advanced nonsquamous nonsmall-cell lung cancer: updated survival analysis of the AVAPERL (MO22089) randomized phase III trial

Barlesi, F. ; Scherpereel, A. ; Gorbunova, V. ; Gervais, R. ; Vikström, A. ; Chouaid, C. ; Chella, A. ; Kim, J.H. ; Ahn, M.J. ; Reck, M. ; Pazzola, A. ; Kim, H.T. ; Aerts, J.G ; Morando, C. ; Loundou, A. ; Groen, H.J.M. ; Rittmeyer, A.

Annals of oncology, 2014-05, Vol.25 (5), p.1044-1052 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
18
Pluripotent stem cells escape from senescence-associated DNA methylation changes
Pluripotent stem cells escape from senescence-associated DNA methylation changes
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pluripotent stem cells escape from senescence-associated DNA methylation changes

Koch, Carmen M ; Reck, Kristina ; Shao, Kaifeng ; Lin, Qiong ; Joussen, Sylvia ; Ziegler, Patrick ; Walenda, Gudrun ; Drescher, Wolf ; Opalka, Bertram ; May, Tobias ; Brümmendorf, Tim ; Zenke, Martin ; Saric, Tomo ; Wagner, Wolfgang

Genome research, 2013-02, Vol.23 (2), p.248-259 [Periódico revisado por pares]

United States: Cold Spring Harbor Laboratory Press

Texto completo disponível

Citações Citado por
19
A phase II double-blind study to investigate efficacy and safety of two doses of the triple angiokinase inhibitor BIBF 1120 in patients with relapsed advanced non-small-cell lung cancer
A phase II double-blind study to investigate efficacy and safety of two doses of the triple angiokinase inhibitor BIBF 1120 in patients with relapsed advanced non-small-cell lung cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase II double-blind study to investigate efficacy and safety of two doses of the triple angiokinase inhibitor BIBF 1120 in patients with relapsed advanced non-small-cell lung cancer

Reck, M. ; Kaiser, R. ; Eschbach, C. ; Stefanic, M. ; Love, J. ; Gatzemeier, U. ; Stopfer, P. ; von Pawel, J.

Annals of oncology, 2011-06, Vol.22 (6), p.1374-1381 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
20
Sunitinib Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer: A Phase III Trial
Sunitinib Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer: A Phase III Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Sunitinib Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer: A Phase III Trial

SCAGLIOTTI, Giorgio V ; KRZAKOWSKI, Maciej ; PAPAI, Zsolt S ; KARASEVA, Nina ; THONGPRASERT, Sumitra ; DALMAU PORTULAS, Elsa ; PAWEL, Joachim Von ; KE ZHANG ; SELARU, Paulina ; TYE, Lesley ; CHAO, Richard C ; GOVINDAN, Ramaswamy ; SZCZESNA, Aleksandra ; STRAUSZ, Janos ; MAKHSON, Anatoly ; RECK, Martin ; WIERZBICKI, Rafal F ; ALBERT, Istvan ; THOMAS, Michael ; ABRAO MIZIARA, Jose Elias

Journal of clinical oncology, 2012-06, Vol.30 (17), p.2070-2078 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
previous page 1 Resultados 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (67)

Data de Publicação 

De até
Refinar
  1. Antes de2002  (6)
  2. 2002Até2006  (12)
  3. 2007Até2011  (11)
  4. 2012Até2017  (29)
  5. Após 2017  (12)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (67)
  2. Japonês  (12)
  3. Russo  (4)
  4. Alemão  (2)
  5. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.